MONDAY, Dec. 15, 2025 (HealthDay News) — Doing nothing at all to manage a common fetal heart defect might improve the ...
Nicklaus Children's Heart Institute Launches Bedside Transcatheter PDA Closure Offering for Newborns
New innovative capability brings lifesaving cardiac care directly to the NICU, reducing risks associated with transporting fragile premature infants. MIAMI , Sept. 22, 2025 /PRNewswire/ -- Nicklaus ...
The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U ...
First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system ...
Medical Device Network on MSN
Abbott secures FDA and CE mark approvals for Amplatzer delivery system
Abbott has secured the US Food and Drug Administration (FDA) and CE Mark approvals for its Amplatzer Piccolo delivery system, designed for premature infants diagnosed with patent ductus arteriosus ...
Abbott (NYSE: ABT) received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo ...
Credit: Getty Images. Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease. Although the majority of congenital heart diseases (CHD) are ...
When the PDA is large, the baby will show signs and symptoms of a failing heart soon after birth. Such infants have rapid heart rates, are easily tired, remain persistently breathless, or have fast ...
Patent ductus arteriosus (PDA), one of the more common cardiac defects present at birth, is the persistence of an opening between the pulmonary artery and aorta. This opening is as a result of failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results